NM_004613.4:c.1796A>T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004613.4(TGM2):c.1796A>T(p.Gln599Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000356 in 1,461,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004613.4 missense
Scores
Clinical Significance
Conservation
Publications
- type 2 diabetes mellitusInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000757 AC: 19AN: 250948 AF XY: 0.0000959 show subpopulations
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461718Hom.: 0 Cov.: 31 AF XY: 0.0000481 AC XY: 35AN XY: 727142 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1796A>T (p.Q599L) alteration is located in exon 12 (coding exon 12) of the TGM2 gene. This alteration results from a A to T substitution at nucleotide position 1796, causing the glutamine (Q) at amino acid position 599 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at